Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""T-Lymphocytes"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 165412

Starter badań:

Tytuł:
CD4 helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment.
Autorzy:
Lei X; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.; Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
Khatri I; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.
de Wit T; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.; Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
de Rink I; Genomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Nieuwland M; Genomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Kerkhoven R; Genomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
van Eenennaam H; Aduro Biotech Europe B.V, Oss, The Netherlands.
Sun C; Immune Regulation in Cancer, German Cancer Research Center, Heidelberg, Germany.
Garg AD; Laboratory of Cell Stress & Immunity, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium.
Borst J; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands. .; Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands. .
Xiao Y; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands. .; Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2023 Jan 13; Vol. 14 (1), pp. 217. Date of Electronic Publication: 2023 Jan 13.
Typ publikacji:
Journal Article
MeSH Terms:
CD8-Positive T-Lymphocytes*
Neoplasms*/metabolism
Humans ; Antigen Presentation ; T-Lymphocytes, Cytotoxic ; Dendritic Cells ; T-Lymphocytes, Helper-Inducer/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Szczegóły
Tytuł:
Regulatory T-cell-derived interleukin-15 shapes cytotoxic T cell memory.
Autorzy:
Geginat J; University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy.; Fondazione Istituto Nazionale di Genetica Molecolare 'Romeo ed Enrica Invernizzi', Milan, Italy.
Granucci F; University of Milano-Bicocca, Department of Biotechnology and Biosciences, Milan, Italy.
Pokaż więcej
Źródło:
European journal of immunology [Eur J Immunol] 2023 Jan; Vol. 53 (1), pp. e2250238. Date of Electronic Publication: 2022 Dec 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
T-Lymphocytes, Regulatory*
Antineoplastic Agents*
Mice ; Humans ; Animals ; T-Lymphocytes, Cytotoxic ; Interleukin-15 ; Memory T Cells ; CD8-Positive T-Lymphocytes ; Forkhead Transcription Factors ; Interleukin-2
Czasopismo naukowe
Szczegóły
Tytuł:
Transfer of mesenchymal stem cell mitochondria to CD4 T cells contributes to repress Th1 differentiation by downregulating T-bet expression.
Autorzy:
Akhter W; Institute for Regenerative Medicine and Biotherapy (IRMB), INSERM U1183, Université de Montpellier, 34295, Montpellier, France.
Nakhle J; Institute for Regenerative Medicine and Biotherapy (IRMB), INSERM U1183, Université de Montpellier, 34295, Montpellier, France.; IGF, CNRS, INSERM, Université de Montpellier, Montpellier, France.; IGMM, CNRS, Université de Montpellier, Montpellier, France.
Vaillant L; Institute for Regenerative Medicine and Biotherapy (IRMB), INSERM U1183, Université de Montpellier, 34295, Montpellier, France.
Garcin G; Institute for Regenerative Medicine and Biotherapy (IRMB), INSERM U1183, Université de Montpellier, 34295, Montpellier, France.
Le Saout C; Institute for Regenerative Medicine and Biotherapy (IRMB), INSERM U1183, Université de Montpellier, 34295, Montpellier, France.
Simon M; Institute for Regenerative Medicine and Biotherapy (IRMB), INSERM U1183, Université de Montpellier, 34295, Montpellier, France.
Crozet C; Institute for Regenerative Medicine and Biotherapy (IRMB), INSERM U1183, Université de Montpellier, 34295, Montpellier, France.; INM, INSERM, Université de Montpellier, Montpellier, France.
Djouad F; Institute for Regenerative Medicine and Biotherapy (IRMB), INSERM U1183, Université de Montpellier, 34295, Montpellier, France.
Jorgensen C; Institute for Regenerative Medicine and Biotherapy (IRMB), INSERM U1183, Université de Montpellier, 34295, Montpellier, France.; CHU Montpellier, Montpellier, France.
Vignais ML; Institute for Regenerative Medicine and Biotherapy (IRMB), INSERM U1183, Université de Montpellier, 34295, Montpellier, France.; IGF, CNRS, INSERM, Université de Montpellier, Montpellier, France.
Hernandez J; Institute for Regenerative Medicine and Biotherapy (IRMB), INSERM U1183, Université de Montpellier, 34295, Montpellier, France. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2023 Jan 24; Vol. 14 (1), pp. 12. Date of Electronic Publication: 2023 Jan 24.
Typ publikacji:
Journal Article
MeSH Terms:
CD4-Positive T-Lymphocytes*/metabolism
CD4-Positive T-Lymphocytes*/physiology
Mesenchymal Stem Cells*/metabolism
Mitochondria*/genetics
Mitochondria*/metabolism
Mitochondria*/physiology
Th1 Cells*/metabolism
Animals ; Mice ; Cell Differentiation ; Cells, Cultured ; Cytokines/metabolism ; T-Lymphocytes, Regulatory ; Th17 Cells
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ly-6A-Induced Growth Inhibition and Cell Death in a Transformed CD4 T Cell Line: Role of Tumor Necrosis Factor-α.
Autorzy:
Patel AG; Department of Biology, Villanova University, Villanova, PA, 19085, USA.
Moxham S; Department of Biology, Villanova University, Villanova, PA, 19085, USA.
Bamezai AK; Department of Biology, Villanova University, Villanova, PA, 19085, USA. .
Pokaż więcej
Źródło:
Archivum immunologiae et therapiae experimentalis [Arch Immunol Ther Exp (Warsz)] 2023 Feb 01; Vol. 71 (1), pp. 4. Date of Electronic Publication: 2023 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
T-Lymphocytes*
Tumor Necrosis Factor-alpha*/metabolism
Humans ; Growth Differentiation Factor 10/metabolism ; Lymphocyte Activation ; Cell Line ; Antigens/metabolism ; Apoptosis ; CD4-Positive T-Lymphocytes ; Transforming Growth Factor beta/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
Once upon a prime: DCs shape cancer immunity.
Autorzy:
Zagorulya M; Department of Biology, MIT, Cambridge, MA 02139, USA; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA.
Spranger S; Department of Biology, MIT, Cambridge, MA 02139, USA; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA; Ludwig Center at MIT's Koch Institute for Integrative Cancer Research, Cambridge, MA 02139, USA; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA. Electronic address: .
Pokaż więcej
Źródło:
Trends in cancer [Trends Cancer] 2023 Feb; Vol. 9 (2), pp. 172-184. Date of Electronic Publication: 2022 Nov 07.
Typ publikacji:
Journal Article; Review
MeSH Terms:
CD8-Positive T-Lymphocytes*
Neoplasms*/pathology
Humans ; Dendritic Cells ; T-Lymphocytes, Cytotoxic ; Lymphocyte Activation ; Tumor Microenvironment
Czasopismo naukowe
Szczegóły
Tytuł:
Characterization of proteogenomic signatures of differentiation of CD4+ T cell subsets.
Autorzy:
Kanno T; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan.
Konno R; Department of Applied Genomics Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan.
Miyako K; Department of Applied Genomics Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan.
Nakajima T; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan.
Yokoyama S; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan.
Sasamoto S; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan.
Asou HK; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan.
Ohzeki J; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan.
Kawashima Y; Department of Applied Genomics Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan.
Hasegawa Y; Department of Applied Genomics Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan.
Ohara O; Department of Applied Genomics Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan.
Endo Y; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan.; Department of Omics Medicine, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Pokaż więcej
Źródło:
DNA research : an international journal for rapid publication of reports on genes and genomes [DNA Res] 2023 Feb 01; Vol. 30 (1).
Typ publikacji:
Journal Article
MeSH Terms:
CD4-Positive T-Lymphocytes*/metabolism
Proteogenomics*
T-Lymphocyte Subsets/metabolism ; T-Lymphocytes, Helper-Inducer/metabolism ; Cell Differentiation/genetics
Czasopismo naukowe
Szczegóły
Tytuł:
Decreased ratio of FOXP3 T cells in peripheral blood is associated with unexplained infertility and ART failure.
Autorzy:
Velichkov A; Laboratory of Reproductive OMICs Technologies, Institute of Biology and Immunology of Reproduction 'Acad. Kiril Bratanov', Bulgarian Academy of Sciences, Sofia, Bulgaria.
Susurkova R; Laboratory of Reproductive OMICs Technologies, Institute of Biology and Immunology of Reproduction 'Acad. Kiril Bratanov', Bulgarian Academy of Sciences, Sofia, Bulgaria.
Muhtarova M; National Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Bulgaria.
Guenova M; National Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Bulgaria.
Muylder BC; Institut Cochin, INSERM U1016, CNRS UMR8104, Universite de Paris, Paris, France.
Cheynier R; Institut Cochin, INSERM U1016, CNRS UMR8104, Universite de Paris, Paris, France.
Nikolov G; Medical Center 'Reprobiomed', Sofia, Bulgaria.
Konova E; Medical University-Pleven, Bulgaria.
Terzieva V; Laboratory of Reproductive OMICs Technologies, Institute of Biology and Immunology of Reproduction 'Acad. Kiril Bratanov', Bulgarian Academy of Sciences, Sofia, Bulgaria; University Hospital 'Lozenetz', Faculty of Medicine, Sofia University 'Sv. Kliment Ohridski', Sofia, Bulgaria. Electronic address: velislava_.
Pokaż więcej
Źródło:
Journal of reproductive immunology [J Reprod Immunol] 2023 Feb; Vol. 155, pp. 103793. Date of Electronic Publication: 2022 Dec 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
T-Lymphocytes, Regulatory*/metabolism
Infertility*
Pregnancy ; Humans ; Female ; CD4-Positive T-Lymphocytes/metabolism ; Leukocyte Common Antigens/metabolism ; Immune Tolerance ; Forkhead Transcription Factors/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
IFNγ signaling in cytotoxic T cells restricts anti-tumor responses by inhibiting the maintenance and diversity of intra-tumoral stem-like T cells.
Autorzy:
Mazet JM; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Mahale JN; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Tong O; Department of Oncology, University of Oxford, Oxford, UK.
Watson RA; Department of Oncology, University of Oxford, Oxford, UK.
Lechuga-Vieco AV; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Pirgova G; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Lau VWC; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Attar M; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Koneva LA; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Sansom SN; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Fairfax BP; Department of Oncology, University of Oxford, Oxford, UK.
Gérard A; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2023 Jan 19; Vol. 14 (1), pp. 321. Date of Electronic Publication: 2023 Jan 19.
Typ publikacji:
Journal Article
MeSH Terms:
T-Lymphocytes, Cytotoxic*/metabolism
Melanoma*/therapy
Melanoma*/drug therapy
Mice ; Animals ; CD8-Positive T-Lymphocytes ; Clone Cells/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
Impact of SARS-CoV-2 exposure history on the T cell and IgG response.
Autorzy:
Keeton R; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Tincho MB; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Suzuki A; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Benede N; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Ngomti A; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Baguma R; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Chauke MV; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Mennen M; Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; South African Medical Research Council Extramural Unit on Intersection of Non-communicable Diseases and Infectious Diseases, University of Cape Town, Cape Town, South Africa.
Skelem S; Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; South African Medical Research Council Extramural Unit on Intersection of Non-communicable Diseases and Infectious Diseases, University of Cape Town, Cape Town, South Africa.
Adriaanse M; Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; South African Medical Research Council Extramural Unit on Intersection of Non-communicable Diseases and Infectious Diseases, University of Cape Town, Cape Town, South Africa.
Grifoni A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.
Weiskopf D; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.
Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA, USA.
Bekker LG; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
Gray G; South African Medical Research Council, Cape Town, South Africa.
Ntusi NAB; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; South African Medical Research Council Extramural Unit on Intersection of Non-communicable Diseases and Infectious Diseases, University of Cape Town, Cape Town, South Africa; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa.
Burgers WA; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa. Electronic address: .
Riou C; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa. Electronic address: .
Pokaż więcej
Źródło:
Cell reports. Medicine [Cell Rep Med] 2023 Jan 17; Vol. 4 (1), pp. 100898. Date of Electronic Publication: 2022 Dec 22.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
Immunoglobulin G*
T-Lymphocytes*
Humans ; Antibody Formation ; CD4-Positive T-Lymphocytes ; SARS-CoV-2
Czasopismo naukowe
Szczegóły
Tytuł:
SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19.
Autorzy:
Stanevich OV; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Alekseeva EI; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia. .
Sergeeva M; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Fadeev AV; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Komissarova KS; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Ivanova AA; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Simakova TS; Parseq Lab Co. Ltd, Saint Petersburg, Russia.
Vasilyev KA; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Shurygina AP; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Stukova MA; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Safina KR; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia.
Nabieva ER; A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia.
Garushyants SK; A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia.; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.
Klink GV; A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia.
Bakin EA; First Pavlov State Medical University, Saint-Petersburg, Russia.; Bioinformatics Institute, Saint Petersburg, Russia.
Zabutova JV; City Hospital 31, Saint-Petersburg, Russia.
Kholodnaia AN; First Pavlov State Medical University, Saint-Petersburg, Russia.; City Hospital 31, Saint-Petersburg, Russia.
Lukina OV; First Pavlov State Medical University, Saint-Petersburg, Russia.
Skorokhod IA; City Hospital 31, Saint-Petersburg, Russia.
Ryabchikova VV; City Hospital 31, Saint-Petersburg, Russia.
Medvedeva NV; City Hospital 31, Saint-Petersburg, Russia.
Lioznov DA; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.; First Pavlov State Medical University, Saint-Petersburg, Russia.
Danilenko DM; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Chudakov DM; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia.; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia.
Komissarov AB; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Bazykin GA; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia. .; A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2023 Jan 10; Vol. 14 (1), pp. 149. Date of Electronic Publication: 2023 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
T-Lymphocytes, Cytotoxic*
COVID-19*
Humans ; SARS-CoV-2 ; CD8-Positive T-Lymphocytes ; Antibodies, Neutralizing ; Antibodies, Viral ; Spike Glycoprotein, Coronavirus
Czasopismo naukowe
Szczegóły
Tytuł:
Differential CpG DNA methylation of peripheral B cells, CD4 T cells, and salivary gland tissues in IgG4-related disease.
Autorzy:
Wu X; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Clinical Biobank, Department of Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Wang A; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Wang M; Department of Stomatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Peng Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Chen Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Li J; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Liu Z; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Lu H; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Zhou J; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Peng L; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Zhao Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Zeng X; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Fei Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. .; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. .; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China. .
Zhang W; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. .; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. .; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China. .
Pokaż więcej
Źródło:
Arthritis research & therapy [Arthritis Res Ther] 2023 Jan 07; Vol. 25 (1), pp. 4. Date of Electronic Publication: 2023 Jan 07.
Typ publikacji:
Journal Article
MeSH Terms:
Immunoglobulin G4-Related Disease*/genetics
T-Lymphocytes*
B-Lymphocytes*
Humans ; CD4-Positive T-Lymphocytes ; DNA Methylation/genetics ; Fibrosis ; Salivary Glands/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
IL-10-producing Th1 cells possess a distinct molecular signature in malaria
Autorzy:
Edwards CL; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; University of Queensland, School of Medicine, Brisbane, Australia.
Ng SS; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Griffith University, School of Natural Sciences, Nathan, Australia.; Institute of Experimental Oncology, University of Bonn, Bonn, Germany.
de Labastida Rivera F; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Corvino D; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Institute of Experimental Oncology, University of Bonn, Bonn, Germany.
Engel JA; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Montes de Oca M; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; York Biomedical Research Institute, Hull York Medical School, University of York, York, United Kingdom.
Bukali L; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; University of Queensland, School of Medicine, Brisbane, Australia.
Frame TC; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; University of Queensland, School of Medicine, Brisbane, Australia.
Bunn PT; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Chauhan SB; Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Singh SS; Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Wang Y; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Griffith University, School of Natural Sciences, Nathan, Australia.
Na J; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; University of Queensland, School of Medicine, Brisbane, Australia.
Amante FH; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Loughland JR; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Soon MS; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Waddell N; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Mukhopadhay P; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Koufariotis LT; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Johnston RL; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Lee JS; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Kuns R; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Zhang P; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Clinical Research Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington, USA.
Boyle MJ; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Hill GR; Clinical Research Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington, USA.
McCarthy JS; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Victorian Infectious Diseases Services, Doherty Institute, University of Melbourne, Melbourne, Australia.
Kumar R; Centre of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Engwerda CR; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Pokaż więcej
Źródło:
The Journal of clinical investigation [J Clin Invest] 2023 Jan 03; Vol. 133 (1). Date of Electronic Publication: 2023 Jan 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
T-Lymphocytes, Regulatory*
Malaria*/genetics
Mice ; Animals ; Humans ; Th1 Cells ; Interleukin-10 ; Mice, Inbred C57BL ; CD4-Positive T-Lymphocytes
Czasopismo naukowe
Szczegóły
Tytuł:
Inhibition of Pyruvate Dehydrogenase Kinase 4 in CD4 T Cells Ameliorates Intestinal Inflammation.
Autorzy:
Lee H; Research Institute of Aging and Metabolism, Kyungpook National University, Daegu, Republic of Korea.
Jeon JH; Research Institute of Aging and Metabolism, Kyungpook National University, Daegu, Republic of Korea; Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea.
Lee YJ; Cell & Matrix Research Institute, Kyungpook National University, Daegu, Republic of Korea.
Kim MJ; Research Institute of Aging and Metabolism, Kyungpook National University, Daegu, Republic of Korea.
Kwon WH; Leading-Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu, Republic of Korea.
Chanda D; Research Institute of Aging and Metabolism, Kyungpook National University, Daegu, Republic of Korea.
Thoudam T; Research Institute of Aging and Metabolism, Kyungpook National University, Daegu, Republic of Korea.
Pagire HS; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea.
Pagire SH; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea.
Ahn JH; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea.
Harris RA; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, Kansas.
Kim ES; Division of Gastroenterology, Department of Internal Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Republic of Korea. Electronic address: .
Lee IK; Research Institute of Aging and Metabolism, Kyungpook National University, Daegu, Republic of Korea; Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Republic of Korea. Electronic address: .
Pokaż więcej
Źródło:
Cellular and molecular gastroenterology and hepatology [Cell Mol Gastroenterol Hepatol] 2023; Vol. 15 (2), pp. 439-461. Date of Electronic Publication: 2022 Oct 10.
Typ publikacji:
Journal Article
MeSH Terms:
Colitis*/chemically induced
Colitis*/pathology
T-Lymphocytes*/metabolism
Animals ; Mice ; Calcium/metabolism ; CD4-Positive T-Lymphocytes/metabolism ; Inflammation/pathology ; Mice, Knockout ; Gene Deletion
Czasopismo naukowe
Szczegóły
Tytuł:
Regulatory T cell-derived interleukin-15 promotes the diversity of immunological memory.
Autorzy:
Madi A; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120, Heidelberg, Germany.
Wu J; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Ma S; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Weisshaar N; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Mieg A; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120, Heidelberg, Germany.
Hering M; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120, Heidelberg, Germany.
Ming Y; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Zettl F; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120, Heidelberg, Germany.
Mohr K; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Ten Bosch N; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Helmholtz Institute for Translational Oncology (HI-TRON), Mainz, Germany.
Schlimbach T; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Hertel F; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Cui G; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120, Heidelberg, Germany.; Helmholtz Institute for Translational Oncology (HI-TRON), Mainz, Germany.
Pokaż więcej
Źródło:
European journal of immunology [Eur J Immunol] 2023 Jan; Vol. 53 (1), pp. e2149400. Date of Electronic Publication: 2022 Nov 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
T-Lymphocytes, Regulatory*
Lymphocytic Choriomeningitis*
Mice ; Animals ; Lymphocytic choriomeningitis virus ; Immunologic Memory ; Interleukin-15 ; CD8-Positive T-Lymphocytes ; Mice, Inbred C57BL ; Interleukin-2
Czasopismo naukowe
Szczegóły
Tytuł:
From thymus to tissues and tumors: A review of T-cell biology.
Autorzy:
Chopp L; Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda.
Redmond C; Clinical Fellowship Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda.
O'Shea JJ; Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda.
Schwartz DM; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh. Electronic address: .
Pokaż więcej
Źródło:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2023 Jan; Vol. 151 (1), pp. 81-97. Date of Electronic Publication: 2022 Oct 19.
Typ publikacji:
Review; Journal Article; Research Support, N.I.H., Intramural
MeSH Terms:
T-Lymphocytes*
Neoplasms*
Humans ; Adaptive Immunity ; Cytokines ; Immunity, Cellular ; CD8-Positive T-Lymphocytes
Czasopismo naukowe
Szczegóły
Tytuł:
Immunophenotyping characteristics of COVID-19 patients: Peripheral blood CD8+ HLA-DR+ T cells as a biomarker for mortality outcome.
Autorzy:
Mirsharif ES; Immunoregulation Research Center, Shahed University, Tehran, Iran.
Chenary MR; Simorgh Clinical Laboratory, Tehran, Iran.
Bozorgmehr M; Simorgh Clinical Laboratory, Tehran, Iran.
Mohammadi S; Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Hashemi SM; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ardestani SK; Department of Immunology, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Beigmohammadi MT; Department of Anesthesiology and Intensive Care, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Abdollahi A; Department of Pathology, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Sadeghipour A; Medicine Department of Pathology, School of Medicine, Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Kariminia A; School of Medicine, University of Washington, Seattle, Washington, USA.
Tuserkani F; Immunoregulation Research Center, Shahed University, Tehran, Iran.
Ghazanfari T; Immunoregulation Research Center, Shahed University, Tehran, Iran.; Simorgh Clinical Laboratory, Tehran, Iran.
Pokaż więcej
Źródło:
Journal of medical virology [J Med Virol] 2023 Jan; Vol. 95 (1), pp. e28192. Date of Electronic Publication: 2022 Oct 19.
Typ publikacji:
Journal Article
MeSH Terms:
CD4-Positive T-Lymphocytes*
COVID-19*/diagnosis
Humans ; Immunophenotyping ; Iran ; HLA-DR Antigens/analysis ; CD8-Positive T-Lymphocytes ; Biomarkers
Czasopismo naukowe
Szczegóły
Tytuł:
CD4 T cells drive an inflammatory, TNF-α/IFN-rich tumor microenvironment responsive to chemotherapy.
Autorzy:
Tilsed CM; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia; School of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia; Institute for Respiratory Health, Perth, WA 6101, Australia.
Principe N; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia; School of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia; Institute for Respiratory Health, Perth, WA 6101, Australia.
Kidman J; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia; School of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia; Institute for Respiratory Health, Perth, WA 6101, Australia.
Chin WL; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia; Medical School, University of Western Australia, Crawley, WA 6009, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, WA 6009, Australia.
Orozco Morales ML; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia; School of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia; Institute for Respiratory Health, Perth, WA 6101, Australia; Telethon Kids Institute, University of Western Australia, West Perth, WA 6872, Australia.
Zemek RM; Telethon Kids Institute, University of Western Australia, West Perth, WA 6872, Australia.
Chee J; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia; School of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia; Institute for Respiratory Health, Perth, WA 6101, Australia.
Islam R; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia.
Fear VS; Telethon Kids Institute, University of Western Australia, West Perth, WA 6872, Australia.
Forbes C; Telethon Kids Institute, University of Western Australia, West Perth, WA 6872, Australia.
Aston WJ; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia.
Jansen M; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia.
Chopra A; Institute of Immunology and Infectious Diseases, Murdoch University, Murdoch, WA 6150, Australia.
Lassmann T; Telethon Kids Institute, University of Western Australia, West Perth, WA 6872, Australia.
Nowak AK; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia; Institute for Respiratory Health, Perth, WA 6101, Australia; Medical School, University of Western Australia, Crawley, WA 6009, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, WA 6009, Australia.
Fisher SA; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia; School of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia; Institute for Respiratory Health, Perth, WA 6101, Australia.
Lake RA; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia; School of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia; Institute for Respiratory Health, Perth, WA 6101, Australia.
Lesterhuis WJ; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia; School of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia; Institute for Respiratory Health, Perth, WA 6101, Australia; Telethon Kids Institute, University of Western Australia, West Perth, WA 6872, Australia. Electronic address: .
Pokaż więcej
Źródło:
Cell reports [Cell Rep] 2022 Dec 27; Vol. 41 (13), pp. 111874.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
T-Lymphocytes*
Neoplasms*/pathology
Animals ; Mice ; Tumor Necrosis Factor-alpha/metabolism ; Tumor Microenvironment ; Cyclophosphamide/pharmacology ; Cyclophosphamide/therapeutic use ; Cyclophosphamide/metabolism ; CD4-Positive T-Lymphocytes/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
Reduced Number and Immune Dysfunction of CD4+ T Cells in Obesity Accelerate Colorectal Cancer Progression.
Autorzy:
Yamada K; Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan.
Saito M; Department of Disaster and Emergency and Critical Care Medicine, Graduate School of Medicine, Kobe University, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
Ando M; Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan.
Abe T; Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan.
Mukoyama T; Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan.
Agawa K; Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan.
Watanabe A; Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan.
Takamura S; Department of Immunology, Kindai University Faculty of Medicine, 377-2 Ono-higashi, Osakasayama 589-0014, Japan.
Fujita M; Center for Medical Education and Clinical Training, Kindai University Faculty of Medicine, 377-2 Onohigashi, Osaka 589-0014, Japan.
Urakawa N; Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan.
Hasegawa H; Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan.
Kanaji S; Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan.
Matsuda T; Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan.
Oshikiri T; Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan.
Kakeji Y; Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan.
Yamashita K; Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan.
Pokaż więcej
Źródło:
Cells [Cells] 2022 Dec 25; Vol. 12 (1). Date of Electronic Publication: 2022 Dec 25.
Typ publikacji:
Journal Article
MeSH Terms:
CD4-Positive T-Lymphocytes*
Colorectal Neoplasms*/complications
Mice ; Animals ; Programmed Cell Death 1 Receptor/metabolism ; Obesity/pathology ; CD8-Positive T-Lymphocytes ; Neoplastic Processes ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Protocol to isolate and enrich mouse splenic naive CD4 cell induction.
Autorzy:
Harada Y; Department of Gastroenterology, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Miyamoto K; Miyarisan Pharm. Co. Ltd., Tokyo, Japan.
Sujino T; Center for Diagnostic and Therapeutic Endoscopy, Keio University Hospital, Tokyo, Japan. Electronic address: .
Pokaż więcej
Źródło:
STAR protocols [STAR Protoc] 2022 Dec 16; Vol. 3 (4), pp. 101728. Date of Electronic Publication: 2022 Sep 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
CD8-Positive T-Lymphocytes*
Intestinal Mucosa*
Mice ; Animals ; CD4-Positive T-Lymphocytes
Czasopismo naukowe
Szczegóły
Tytuł:
Dysfunctional Sars-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19.
Autorzy:
Ogura H; Department of Microbiology, Hyogo Medical University, Hyogo, Japan. .
Gohda J; Research Center for Asian Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Lu X; Laboratory of Molecular Immunology, Immunology Frontier Research Center, Osaka University, Suita, Japan.
Yamamoto M; Research Center for Asian Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Takesue Y; Department of Infection Control and Prevention, Hyogo Medical University, Hyogo, Japan.; Tokoname City Hospital, Aichi, Japan.
Son A; Department of Microbiology, Hyogo Medical University, Hyogo, Japan.
Doi S; Kawanishi City Hospital, Hyogo, Japan.
Matsushita K; Kyoritsu Hospital, Hyogo, Japan.
Isobe F; Kyowa Marina Hospital/Wellhouse Nishinomiya, Hyogo, Japan.
Fukuda Y; Dainikyoritsu Hospital, Hyogo, Japan.
Huang TP; Kyoritsu Onsen Hospital, Hyogo, Japan.
Ueno T; Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Mambo N; Department of Emergency and Critical Care Medicine, Hyogo Medical University, Hyogo, Japan.
Murakami H; Department of Emergency and Critical Care Medicine, Hyogo Medical University, Hyogo, Japan.
Kawaguchi Y; Research Center for Asian Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Inoue JI; Research Platform Office, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Shirai K; Department of Emergency and Critical Care Medicine, Hyogo Medical University, Hyogo, Japan.
Yamasaki S; Laboratory of Molecular Immunology, Immunology Frontier Research Center, Osaka University, Suita, Japan.; Department of Molecular Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.; Division of Molecular Design, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.; Division of Molecular Immunology, Medical Mycology Research Center, Chiba University, Chiba, Japan.
Hirata JI; Department of Emergency and Critical Care Medicine, Hyogo Medical University, Hyogo, Japan.
Ishido S; Department of Microbiology, Hyogo Medical University, Hyogo, Japan. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2022 Dec 16; Vol. 13 (1), pp. 7063. Date of Electronic Publication: 2022 Dec 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
CD8-Positive T-Lymphocytes*
COVID-19*
Humans ; SARS-CoV-2 ; T-Lymphocytes, Cytotoxic ; Epitopes, T-Lymphocyte ; HLA-A Antigens
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 165412

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz